More on RADX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (12/3/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:RADX)
Delayed: 2.27 -0.01 (0.44%)
Prev. Close $2.28  
Open$2.27 
52 Wk High$ 
52 Wk Low$ 
Day High$2.27 
Day Low$2.18 
P/E N/A  
EPS$ 
Volume14,578 

Friends, Peers and Foes (?): RAD, BLTE, FPAFY, FPC, HCM (more...)

Aug 28, 2026 08:00 AM Form 6-K Radiopharm Theranostics For: Aug 28
Aug 27, 2026 08:00 AM Form 6-K Radiopharm Theranostics For: Aug 27
Aug 26, 2026 08:00 AM Form 6-K Radiopharm Theranostics For: Aug 26
Aug 26, 2026 07:00 AM Radiopharm doses first patient in second RV-01 trial cohort
Aug 26, 2026 07:00 AM Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors
Aug 20, 2026 08:00 AM Form 6-K Radiopharm Theranostics For: Aug 20
Aug 20, 2026 07:01 AM Radiopharm trial advances to higher dose in HER2+ cancer study
Aug 20, 2026 07:00 AM Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Clinical Trial
Aug 17, 2026 08:00 AM Form 6-K Radiopharm Theranostics For: Aug 17
Aug 17, 2026 07:30 AM Radiopharm sets FDA meeting for RAD101 brain metastases trial design
View All Articles

Entities mentioned with RADX

View All Entities